RNS Number : 2025X
Quadgas Finance PLC
17 December 2019
 

Publication of Prospectus

The following Prospectus has been approved by the Financial Conduct Authority and is available for viewing:

 

The Prospectus dated 16 December 2019 (the "Prospectus") for the update of the £5,000,000,000 Secured Debt Issuance Programme established on 14 December 2017 for the issuance of bonds (the "Programme"), with Quadgas Finance plc as the issuer and Quadgas MidCo Limited and Quadgas PledgeCo Limited as guarantors.

 

To view the Prospectus, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/2025X_1-2019-12-17.pdf

 

A copy of the Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.morningstar.co.uk/uk/NSM.

 

For further information, please contact:

Rob O'Malley

Ashbrook Court, Prologis Park

Central Boulevard

Coventry CV7 8PE

Email: [email protected]

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. The Prospectus is not intended for use in the United States and is not addressed or targeted at U.S. persons and should not be relied upon by any U.S. person. Prior to relying on the information contained in the Prospectus, you must ascertain from the Prospectus whether or not you are one of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement. 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
PDIBSBDDBDBBGCR